Loading...

PE Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405203 100 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405204 500 µg 156€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical data sheet

Product Details

Reactivity
Human,Mouse,Rat,All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References

(PubMed link indicates BioLegend citation)
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  2. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  3. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  4. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  5. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  6. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  7. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  8. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  9. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  10. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  11. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  12. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  13. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  14. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  15. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  16. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  17. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  18. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  19. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  20. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  21. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  22. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  23. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  24. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  25. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  26. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  27. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  28. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  29. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  30. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  31. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  32. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  33. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  34. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  35. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  36. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  37. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  38. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  39. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  40. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  41. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  42. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  43. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  44. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  45. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  46. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  47. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  48. He X, et al. 2014. J Immunol. 193:1314. PubMed
  49. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  50. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  51. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  52. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  53. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  54. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  55. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  56. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  57. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  58. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  59. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  60. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  61. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  62. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  63. Im S, et al. 2016. Nature. 537:417-421. PubMed
  64. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  65. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  66. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  67. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  68. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  69. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  70. Köchl R, et al. 2020. Elife. 9:00. PubMed
  71. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  72. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  73. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  74. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  75. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  76. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  77. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  78. Weiß S, et al. 2020. medRxiv. . PubMed
  79. Gniffke EP, et al. 2020. medRxiv. . PubMed
  80. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  81. Dan JM, et al. 2021. Science. :371. PubMed
  82. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  83. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  84. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  85. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  86. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  87. Wells DK, et al. 2020. Cell. 183:818. PubMed
  88. Biswas S, et al. 2021. Nature. 591:464. PubMed
  89. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  90. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  91. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  92. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  93. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  94. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  95. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  96. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  97. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  98. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  99. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  100. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  101. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  102. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  103. Cao Y, et al. 2022. Nature. 602:657. PubMed
  104. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  105. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  106. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  107. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  108. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  109. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  110. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  111. Cao Y, et al. 2022. Nature. :. PubMed
  112. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  113. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  114. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  115. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  116. Schanda N, et al. 2021. Cells. 10:. PubMed
  117. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  118. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  119. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  120. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  121. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  122. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  123. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  124. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  125. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  126. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  127. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  128. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  129. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  130. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  131. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  132. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  133. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  134. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  135. Campisi L, et al. 2022. Nature. 606:945. PubMed
  136. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  137. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  138. Cao Y, et al. 2023. Nature. 614:521. PubMed
  139. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  140. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  141. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  142. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  143. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  144. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  145. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  146. Feng J, et al. 2022. Immunity. 55:405. PubMed
  147. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  148. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  149. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  150. Ke F, et al. 2023. Elife. 12:. PubMed
  151. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  152. Silva RP, et al. 2023. Elife. 12:. PubMed
  153. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  154. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  155. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  156. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  157. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  158. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  159. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  160. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  161. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  162. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06.17.2019

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account